Javascript must be enabled to continue!
SNAIL MUCIN: A NOVEL BIOACTIVE INGREDIENT IN PHARMACEUTICALS – A REVIEW
View through CrossRef
Snail mucin is popular for its wide range of ingredients and potential benefits. Snail extract’s widespread appearance in different pharmaceutical formulations encourages an investigation into the medical and cosmetic benefits. Its main aims to explain current literature on the variety of snail mucin applications. Typically, we present a review of the uses, global market scenario and research, and limitations to snail mucin. A literature search was conducted on different journals reviewing snail mucin and their application in medical and cosmetic fields examining their uses. Economic reports were also found out for global market scenario. The therapeutic use of snail mucin in medical fields was studied as antimicrobial agents, drug delivery vehicles, antitumor agents, wound healing agents, and biomaterial coatings among others. In addition, the use in cosmetic fields includes antiaging, hydrating, antiacne, scarring, and hyperpigmentation treatments. It is important to highlight that most studies conducted were preclinical or small clinical studies, stressing the need for additional large-scale clinical trials to support these claims. Investigations into the global market found estimates ranging from $457 million to $1.2 billion with upward projections in the upcoming decade. The limitations include ethical habitats for collection, allergy investigation, and missing clinical studies. The findings presented here emphasize the expanding uses of snail mucin and its ingredients alongside a growing market cosmetic industry should consider. We also emphasize the need for appropriate clinical trials into the stated benefits of snail mucin to ensure consumer safety and ethical extraction of mucin.
Innovare Academic Sciences Pvt Ltd
Title: SNAIL MUCIN: A NOVEL BIOACTIVE INGREDIENT IN PHARMACEUTICALS – A REVIEW
Description:
Snail mucin is popular for its wide range of ingredients and potential benefits.
Snail extract’s widespread appearance in different pharmaceutical formulations encourages an investigation into the medical and cosmetic benefits.
Its main aims to explain current literature on the variety of snail mucin applications.
Typically, we present a review of the uses, global market scenario and research, and limitations to snail mucin.
A literature search was conducted on different journals reviewing snail mucin and their application in medical and cosmetic fields examining their uses.
Economic reports were also found out for global market scenario.
The therapeutic use of snail mucin in medical fields was studied as antimicrobial agents, drug delivery vehicles, antitumor agents, wound healing agents, and biomaterial coatings among others.
In addition, the use in cosmetic fields includes antiaging, hydrating, antiacne, scarring, and hyperpigmentation treatments.
It is important to highlight that most studies conducted were preclinical or small clinical studies, stressing the need for additional large-scale clinical trials to support these claims.
Investigations into the global market found estimates ranging from $457 million to $1.
2 billion with upward projections in the upcoming decade.
The limitations include ethical habitats for collection, allergy investigation, and missing clinical studies.
The findings presented here emphasize the expanding uses of snail mucin and its ingredients alongside a growing market cosmetic industry should consider.
We also emphasize the need for appropriate clinical trials into the stated benefits of snail mucin to ensure consumer safety and ethical extraction of mucin.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Abstract A65: Snail, a potent inducer of global DNA methylation in ovarian cancer
Abstract A65: Snail, a potent inducer of global DNA methylation in ovarian cancer
Abstract
Snail plays a critical role in the epithelial to mesenchymal transition (EMT). To investigate the role of Snail in this event, we established inducible Snai...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Ruminococcus torques
is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by
Bacteroides thetaiotaomicron
Ruminococcus torques
is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by
Bacteroides thetaiotaomicron
Abstract
Symbiotic interactions between humans and our communities of resident gut microbes (microbiota) play many roles in health and disease. S...
Abstract 1602: Snail transcription factor regulates nuclear cathepsin L activity
Abstract 1602: Snail transcription factor regulates nuclear cathepsin L activity
Abstract
Triple negative breast cancer (TNBC) are defined as tumors lacking the expression of estrogen receptor-alpha, progesterone receptor and human epidermal grow...
Contribution of snail production to income status of snail farmers in Edo South, Edo State, Nigeria
Contribution of snail production to income status of snail farmers in Edo South, Edo State, Nigeria
This study examined the contribution of snail production to the income status of snail farmers in Edo South Senatorial District, Edo State, Nigeria. The specif...

